Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease.

Pereira JC Jr, Pradella-Hallinan M, Alves RC.

Clinics (Sao Paulo). 2013 Apr;68(4):469-74. doi: 10.6061/clinics/2013(04)06.

2.

Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.

Bauer S, Störmer E, Kerb R, Johne A, Brockmöller J, Roots I.

Eur J Clin Pharmacol. 2002 Dec;58(9):581-5. Epub 2002 Nov 12.

PMID:
12483450
3.

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.

Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD.

Clin Pharmacol Ther. 2001 Oct;70(4):317-26.

PMID:
11673747
4.

Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.

Hafner V, Jäger M, Matthée AK, Ding R, Burhenne J, Haefeli WE, Mikus G.

Clin Pharmacol Ther. 2010 Feb;87(2):191-6. doi: 10.1038/clpt.2009.206. Epub 2009 Nov 18.

PMID:
19924124
5.

Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.

Al-Akoum M, Maunsell E, Verreault R, Provencher L, Otis H, Dodin S.

Menopause. 2009 Mar-Apr;16(2):307-14. doi: 10.1097/gme.0b013e31818572a0.

PMID:
19194342
6.

St John's Wort: effect on CYP3A4 activity.

Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH.

Clin Pharmacol Ther. 2000 May;67(5):451-7.

PMID:
10824623
7.

[St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].

Schempp CM, Müller KA, Winghofer B, Schöpf E, Simon JC.

Hautarzt. 2002 May;53(5):316-21. Review. German.

PMID:
12063742
8.
9.

The recovery time-course of CYP3A after induction by St John's wort administration.

Imai H, Kotegawa T, Tsutsumi K, Morimoto T, Eshima N, Nakano S, Ohashi K.

Br J Clin Pharmacol. 2008 May;65(5):701-7. doi: 10.1111/j.1365-2125.2008.03120.x. Epub 2008 Feb 20.

10.

The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.

Dostalek M, Pistovcakova J, Jurica J, Sulcova A, Tomandl J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):253-7. doi: 10.5507/bp.2011.047.

11.

St John's wort (Hypericum perforatum) in major depression.

Shelton RC.

J Clin Psychiatry. 2009;70 Suppl 5:23-7. doi: 10.4088/JCP.8157su1c.05. Review.

12.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
13.

Effect of antenatal exposure to Saint John's wort (Hypericum) on neurobehavior of developing mice.

Rayburn WF, Christensen HD, Gonzalez CL.

Am J Obstet Gynecol. 2000 Nov;183(5):1225-31.

PMID:
11084570
14.

The interaction between St John's wort and an oral contraceptive.

Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC.

Clin Pharmacol Ther. 2003 Dec;74(6):525-35.

PMID:
14663455
15.

Effect of St John's wort on imatinib mesylate pharmacokinetics.

Frye RF, Fitzgerald SM, Lagattuta TF, Hruska MW, Egorin MJ.

Clin Pharmacol Ther. 2004 Oct;76(4):323-9.

PMID:
15470331
16.

An open-label pilot study of St. John's wort in juvenile depression.

Findling RL, McNamara NK, O'Riordan MA, Reed MD, Demeter CA, Branicky LA, Blumer JL.

J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):908-14.

PMID:
12874492
17.

Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.

Friede M, Henneicke von Zepelin HH, Freudenstein J.

Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S38-41.

PMID:
11518073
18.
19.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
20.

Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.

Dresser GK, Schwarz UI, Wilkinson GR, Kim RB.

Clin Pharmacol Ther. 2003 Jan;73(1):41-50.

PMID:
12545142

Supplemental Content

Support Center